A pathogenetic link between non-alcoholic fatty liver disease and celiac disease

Endocrine

Volumn 43, Issue 1, 2013, Pages 65-67

  Abenavoli, Ludovico ^a   Milic, Natasa ^b   De Lorenzo, Antonino ^c   Luzza, Francesco ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Celiac disease; Intestinal permeability; Microbiota; Non alcoholic fatty liver disease

Indexed keywords

BACTERIAL OVERGROWTH; CELIAC DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GLUTEN FREE DIET; HUMAN; IMMUNE RESPONSE; INSULIN RESISTANCE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIPID PEROXIDATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 84872349378     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9731-y     Document Type: Review

References (25)

1. P. Angulo, Non-alcoholic fatty liver disease. N. Engl. J. Med. 346, 1221-1231 (2002)
2. S. Bellentani, F. Scaglioni, M. Marino et al., Epidemiology of non-alcoholic fatty liver disease. Dig. Dis. 28, 155-161 (2010)
3. G.A. Garinis, B. Fruci, A. Mazza et al., Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study. Int. J. Obes. 34, 1255-1264 (2010)
4. P.H. Green, C. Cellier, Celiac disease. N. Engl. J. Med. 357, 1731-1743 (2007)
5. L. Maiuri, C. Ciacci, I. Ricciardelli et al., Association between innate response to gliadin and activation of pathogenic T cells in celiac disease. Lancet 362, 30-37 (2003)
6. A. Vilppula, K. Kaukinen, L. Luostarinen et al., Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC. Gastroenterol. 9, 49 (2009)
7. U. Volta, Pathogenesis and clinical significance of liver injury in celiac disease. Clin. Rev. Allergy Immunol. 36, 62-70 (2009)
8. C.P. Day, O.F. James, Steatohepatitis: a tale of two "hits"? Gastroenterology 114, 842-845 (1998)
9. C.P. Day, Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int. 26, 1021-1028 (2006)
10. S. Prakash, L. Rodes, M. Coussa-Charley et al., Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 5, 1-86 (2011)
11. J.P. Nolan, The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology 52, 1829-1835 (2010)
12. M.T. DeMeo, E.A. Mutlu, A. Keshavarzian et al., Intestinal permeation and gastrointestinal disease. J. Clin. Gastroenterol. 34, 385-396 (2002)
13. A. Farhadi, S. Gundlapalli, M. Shaikh et al., Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int. 28, 1026-1033 (2008)
14. T.H. Frazier, J.K. DiBaise, C.J. McClain, Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J. Parenter. Enteral. Nutr. 35(5 Suppl), 14S-20S (2011)
15. P. Brun, I. Castagliuolo, V. Di Leo et al., Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G518-G525 (2007)
16. L. Abenavoli, V. Arena, F. Giancotti et al., Celiac disease, primary biliary cirrhosis and helicobacter pylori infection: one link for three diseases. Int. J. Immunopathol. Pharmacol. 23, 1261-1265 (2010)
17. I.R. Korponay-Szabo, T. Halttunen, Z. Szalai et al., In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 53, 641-648 (2004)
18. M.T. Bardella, L. Valenti, C. Pagliari et al., Searching for coeliac disease in patients with non-alcoholic fatty liver disease. Dig. Liver Dis. 36, 333-336 (2004)
19. L. Miele, V. Valenza, G. La Torre et al., Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49, 1877-1887 (2009)
20. A.J. Wigg, I.C. Roberts-Thomson, R.B. Dymock et al., The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48, 206-211 (2001)
21. A.J. Wigg, A.G. Cummins, Reply to Grieco et al. Gut. 49, 596 (2001)
22. A. Grieco, L. Miele, G. Pignatoro et al., Is coeliac disease a confounding factor in the diagnosis of NASH? Gut 49, 596 (2001)
23. V. Nehra, P. Angulo, A.L. Buchman et al., Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig. Dis. Sci. 46, 2347-2352 (2001)
24. O. Loiacono, S. Petta, G. Venezia et al., Anti-tissue transglutaminase antibodies in patients with abnormal liver test: is it always celiac disease? Am. J. Gastroenterol. 100, 2472-2477 (2005)
25. A.R. Rahimi, N.E. Daryani, H. Ghofrani et al., The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran. Turk. J. Gastroenterol. 22, 300-304 (2011)